Combined Effects of Nutritional and Exercise Countermeasures

University of Arkansas1 site in 1 country31 target enrollmentJanuary 2007

ConditionsMuscular Atrophy Muscle Weakness

Overview

Phase: N/A
Intervention: Not specified
Conditions: Muscular Atrophy
Sponsor: University of Arkansas
Enrollment: 31
Locations: 1
Primary Endpoint: Fractional synthetic rate of muscle growth.
Status: Completed
Last Updated: 16 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to see if a combination of resistance exercises and amino acid capsules can reduce muscle loss and maintain muscle function during bedrest. This experiment will imitate many of the physical conditions experienced by astronauts during space flight by examining the effects of resistance exercise or nutrition on muscle during 2 days of bedrest. The diet of astronauts will also be imitated by providing diets in the General Clinic Research Center.

Registry

clinicaltrials.gov

Start Date

January 2007

End Date

June 2009

Last Updated

16 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

University of Arkansas

Eligibility Criteria

Inclusion Criteria

•18-50 years of age
•Availability of transport and ability to report to Research Center at appointed times

Exclusion Criteria

•Subjects with limiting or unstable angina or a cardiology confirmed ECG which demonstrates cardiac abnormalities such as \> 0.2 mV horizontal or downsloping ST segment depression, frequent arrhythmia's (\>10 PVC/min), or valvular disease.
•Subjects with vascular disease as determined by a combination of risk factors of peripheral atherosclerosis, namely hypertension, obesity, diabetes, hypercholesterolemia and/or evidence of venous or arterial insufficiency upon palpitation of femoral, popliteal, and pedal arteries.
•Any history of hypo- or hyper-coagulation disorders including subjects taking Coumadin or with a history of DVT or PE at any point in their lifetime.
•Any subject that has a chronically elevated systolic pressure \>170 or a diastolic blood pressure \> 100 will be excluded. Subjects may be included if they are taking blood pressure medication and have a blood pressure below these criteria.
•Any subject with an uncontrolled metabolic disease including liver or renal disease.
•Fasting blood glucose of \>126 mg/dl on two separate occasions
•Presence of acute illness or metabolically unstable chronic illness.
•Any subject currently on weight-loss diet.
•Inability to abstain from smoking for duration of study.
•Recent ingestion of anabolic steroids (within 6 months).